PATENT CLAIM ANALYSIS

Application Number: 16383311
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-09
Patent Classification: ["435", "183000"]

Abstract:
The present invention relates to a composition for prevention or treatment of sepsis or septic shock, in which the composition includes neoagarooligosaccharide as an active ingredient, and the neoagarooligosaccharide according to the present invention has an excellent effect in terms of immune enhancement by effectively suppressing inflammation, and also exhibits a good effect in preventing sepsis, and therefore can be effectively used in pharmaceuticals and functional foods for prevention or treatment of sepsis or septic shock and immune enhancement.

Claim (Index 10):
A method for preventing or treating sepsis or septic shock in a subject, the method comprising administering to the subject a neoagarooligosaccharide, wherein the neoagarooligosaccharide is prepared from agar or agarose by an agarase gene (DagA) enzyme reaction.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 100.0
- Lexical Diversity: 1.71429
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15534979', '14400293', '14005737', '12227244', '11587377']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.4970825221659871
- 35 USC 102 Novelty (BERT): 0.4885707226629339
- Combined Prediction Score: 0.4962313422156817
- Mean Citation Score: 167.650464
- Max Citation Score: 187.54597
- Similarity Product: 132.72896848271608

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test